AFIB · As filed with the SEC
Acutus Medical balance sheet, by fiscal year
The statement as Acutus Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | 14,019 | 19,170 | 25,584 | 24,071 |
| Marketable securities, short-term | — | — | 44,863 | 76,702 |
| Marketable securities, short-term | 0 | 3,233 | — | — |
| Restricted cash, short-term | 0 | 7,030 | 5,764 | 150 |
| Accounts receivable | 7,878 | 11,353 | 21,085 | 3,633 |
| Inventory | 1,790 | 4,278 | 13,327 | 16,408 |
| Employer retention credit receivable | — | — | 4,703 | — |
| Employer retention credit receivable | — | 0 | — | — |
| Prepaid expenses and other current assets | 641 | 678 | 2,541 | 5,326 |
| Current assets of discontinued operations (Note 3) | 1,250 | 510 | — | — |
| Total current assets | 25,578 | 46,252 | 117,867 | 126,290 |
| Marketable securities, long-term | — | — | 0 | 7,120 |
| Noncurrent assets | ||||
| Property and equipment, net | 517 | 825 | 9,221 | 13,670 |
| Right-of-use assets, net | 2,459 | 3,189 | 3,872 | 4,521 |
| Intangible assets, net | — | — | 1,583 | 5,013 |
| Goodwill | — | — | 0 | 12,026 |
| Other assets | 94 | 94 | 897 | 1,152 |
| Non-current assets of discontinued operations (Note 3) | 0 | 3,600 | — | — |
| Total assets | 28,648 | 53,960 | 133,440 | 169,792 |
| LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | 1,276 | 2,761 | 4,721 | 7,519 |
| Accrued liabilities | 3,006 | 2,887 | 9,686 | 9,096 |
| Contingent consideration, short-term | — | — | 1,800 | 1,500 |
| Contingent consideration, short-term | — | 0 | — | — |
| Operating lease liabilities, short-term | 957 | 718 | 319 | 395 |
| Long-term debt, current portion | 7,005 | 1,864 | — | — |
| Warrant liability | 194 | 409 | 3,346 | — |
| Current liabilities of discontinued operations (Note 3) | 0 | 10,303 | — | — |
| Total current liabilities | 12,438 | 18,942 | 19,872 | 18,510 |
| Operating lease liabilities, long-term | 2,238 | 3,243 | 4,103 | 4,591 |
| Long-term debt | 25,564 | 32,654 | 34,434 | 40,415 |
| Contingent consideration, long-term | — | — | 0 | 500 |
| Other long-term liabilities | — | 0 | 12 | 50 |
| Total liabilities | 40,240 | 54,839 | 58,421 | 64,066 |
| Stockholders' (deficit) equity | ||||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 6,666 shares of the preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value; 260,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 29,912,305 and 29,313,667 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | 30 | 29 | 29 | 28 |
| Additional paid-in capital | 598,670 | 599,935 | 594,173 | 584,613 |
| Accumulated deficit | (609,524) | (599,977) | (518,314) | (478,698) |
| Accumulated other comprehensive loss | (768) | (866) | (869) | (217) |
| Total stockholders' equity | — | — | 75,019 | 105,726 |
| Total stockholders' deficit | (11,592) | (879) | — | — |
| Total liabilities and stockholders' deficit | 28,648 | 53,960 | 133,440 | 169,792 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.